Trials that use: Logistic regression
New to this method? Read the tutorial →
5,900 results
- Study of Plerixafor for Rescue of Poor Mobilizers in Autologous Stem Cell Transplant: Complete Statistical AnalysisIndependent statistical analysis of Study of Plerixafor for Rescue of Poor Mobilizers in Autologous Stem Cell Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Prasugrel in Korean Healthy Male Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Study of Prasugrel in Korean Healthy Male Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01591317).
- Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD: Complete Statistical AnalysisIndependent statistical analysis of Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Produce Prescription Programs in Adults With Overweight or Obesity Experiencing Nutrition Insecurity: Complete Statistical AnalysisIndependent statistical analysis of Study of Produce Prescription Programs in Adults With Overweight or Obesity Experiencing Nutrition Insecurity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Progression to Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Incidence/Management and Treatment: Complete Statistical AnalysisIndependent statistical analysis of Study of Progression to Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Incidence/Management and Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer: primary…
- Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines in a Simulated Post-Exposure Regimen in Adults: Complete Statistical AnalysisIndependent statistical analysis of Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines in a Simulated Post-Exposure Regimen in Adults: primary endpoint results, effect estimate with confidence interval, sample-size…
- Study of Quadrivalent Influenza Vaccine Among Children: Complete Statistical AnalysisIndependent statistical analysis of Study of Quadrivalent Influenza Vaccine Among Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01240746).
- Study of Ramucirumab in Ovarian Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Ramucirumab in Ovarian Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00721162).
- Study of Ravulizumab in Children and Adolescents With Atypical Hemolytic Uremic Syndrome (aHUS): Complete Statistical AnalysisIndependent statistical analysis of Study of Ravulizumab in Children and Adolescents With Atypical Hemolytic Uremic Syndrome (aHUS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Repeat Intranodal Injection of Memgen’s Cancer Vaccine, Ad-ISF35, in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Complete Statistical AnalysisIndependent statistical analysis of Study of Repeat Intranodal Injection of Memgen's Cancer Vaccine, Ad-ISF35, in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): primary endpoint results, effect estimate with confidence interval, sample-size…
- Study of Romiplostim for Chemotherapy Induced Thrombocytopenia: Complete Statistical AnalysisIndependent statistical analysis of Study of Romiplostim for Chemotherapy Induced Thrombocytopenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02052882).
- Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With Anemia: Complete Statistical AnalysisIndependent statistical analysis of Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With Anemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of RSVpreF Vaccination and RSV Challenge in Healthy Adults: Complete Statistical AnalysisIndependent statistical analysis of Study of RSVpreF Vaccination and RSV Challenge in Healthy Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04785612).
- Study of Ruxolitinib in Pancreatic Cancer Patients (Janus 1): Complete Statistical AnalysisIndependent statistical analysis of Study of Ruxolitinib in Pancreatic Cancer Patients (Janus 1): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02117479).
- Study of Safety and Efficacy of an Oral Contraceptive: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety and Efficacy of an Oral Contraceptive: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00391807).
- Study of Safety and Efficacy of an Oral Contraceptive: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety and Efficacy of an Oral Contraceptive: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00932321).
- Study of Safety and Efficacy of Brolucizumab 6 mg Drug Product Intended for Commercialization in Patients With nAMD: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety and Efficacy of Brolucizumab 6 mg Drug Product Intended for Commercialization in Patients With nAMD: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study of Safety and Efficacy of Talimogene Laherparepvec With Cisplatin and Radiotherapy for Treatment of Locally Advanced Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety and Efficacy of Talimogene Laherparepvec With Cisplatin and Radiotherapy for Treatment of Locally Advanced Head and Neck Cancer: primary endpoint results, effect estimate with confidence…
- Study of Safety and Immunogenicity of Fluzone® in Healthy Children: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety and Immunogenicity of Fluzone® in Healthy Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00831675).
- Study of Safety, Pharmacokinetics, and Antitumor Activity of BGB-3245 in Participants With Advanced or Refractory Tumors: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety, Pharmacokinetics, and Antitumor Activity of BGB-3245 in Participants With Advanced or Refractory Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of Safety, Tolerability and Immunogenicity of Gardasil®9 in Immunocompromised Patients: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety, Tolerability and Immunogenicity of Gardasil®9 in Immunocompromised Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Safety, Tolerability, and Efficacy of Ustekinumab for Symptomatic Gastrointestinal Inflammation Associated With Common Variable Immunodeficiency: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety, Tolerability, and Efficacy of Ustekinumab for Symptomatic Gastrointestinal Inflammation Associated With Common Variable Immunodeficiency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of Safety, Tolerability, Pharmacokinetics, and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety, Tolerability, Pharmacokinetics, and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With T2DM: Complete Statistical AnalysisIndependent statistical analysis of Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With T2DM: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Selective BRAF Kinase Inhibitor Dabrafenib Monotherapy Twice Daily and in Combination With Dabrafenib Twice Daily and Trametinib Once Daily in Combination Therapy in Subjects With BRAF V600E Mutation Positive Metastatic (Stage IV) Non-small Cell Lung Cancer.: Complete Statistical AnalysisIndependent statistical analysis of Study of Selective BRAF Kinase Inhibitor Dabrafenib Monotherapy Twice Daily and in Combination With Dabrafenib Twice Daily and Trametinib Once Daily in Combination Therapy in Subjects With BRAF…
- Study of Sonrotoclax (BGB-11417) Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Study of Sonrotoclax (BGB-11417) Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia: Complete Statistical AnalysisIndependent statistical analysis of Study of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03257462).
- Study Of SU011248 In Combination With Docetaxel In Patients With Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study Of SU011248 In Combination With Docetaxel In Patients With Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are Candidates for Systemic Therapy: Complete Statistical AnalysisIndependent statistical analysis of Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are…
- Study Of Sunitinib With Capecitabine In Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study Of Sunitinib With Capecitabine In Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00662025).
- Study Of Sunitinib With S-1 And Cisplatin For Gastric Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study Of Sunitinib With S-1 And Cisplatin For Gastric Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00553696).
- Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Talimogene Laherparepvec In Children With Advanced Non CNS Tumors: Complete Statistical AnalysisIndependent statistical analysis of Study of Talimogene Laherparepvec In Children With Advanced Non CNS Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of TBL 12 Sea Cucumber Extract for Patients With Untreated Asymptomatic Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Study of TBL 12 Sea Cucumber Extract for Patients With Untreated Asymptomatic Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Tecemotide (L-BLP25) in Subjects With Slowly Progressive Multiple Myeloma With no Symptoms and Who Have Had no Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Study of Tecemotide (L-BLP25) in Subjects With Slowly Progressive Multiple Myeloma With no Symptoms and Who Have Had no Chemotherapy: primary endpoint results, effect estimate with confidence interval,…
- Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in Adolescents: Complete Statistical AnalysisIndependent statistical analysis of Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of the Aliviado DSD Caregiving Mastery Program: Complete Statistical AnalysisIndependent statistical analysis of Study of the Aliviado DSD Caregiving Mastery Program: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05630014).
- Study of the Bruton’s Tyrosine Kinase Inhibitor in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of the Effects of Itraconazole and Rifampin on LOXO-305 in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of Study of the Effects of Itraconazole and Rifampin on LOXO-305 in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of the Effects of Oral AT1001 (Migalastat Hydrochloride) in Patients With Fabry Disease: Complete Statistical AnalysisIndependent statistical analysis of Study of the Effects of Oral AT1001 (Migalastat Hydrochloride) in Patients With Fabry Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of the ENTact Septal Staple System for Tissue Approximation During Septoplasty: Complete Statistical AnalysisIndependent statistical analysis of Study of the ENTact Septal Staple System for Tissue Approximation During Septoplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of the Experience of Patients With Osteoporosis Using the Forteo B Pen to Self Administer Once Daily Teriparatide Therapy: Complete Statistical AnalysisIndependent statistical analysis of Study of the Experience of Patients With Osteoporosis Using the Forteo B Pen to Self Administer Once Daily Teriparatide Therapy: primary endpoint results, effect estimate with confidence interval,…
- Study of the MUC1 Peptide-Poly-ICLC Adjuvant Vaccine in Individuals With Advanced Colorectal Adenoma: Complete Statistical AnalysisIndependent statistical analysis of Study of the MUC1 Peptide-Poly-ICLC Adjuvant Vaccine in Individuals With Advanced Colorectal Adenoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Sarcoma and Kidney Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Sarcoma and Kidney Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Advanced Malignancies and Hepatic Impairment: Complete Statistical AnalysisIndependent statistical analysis of Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Advanced Malignancies and Hepatic Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Multiple Myeloma and Renal Disease: Complete Statistical AnalysisIndependent statistical analysis of Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Multiple Myeloma and Renal Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of the Presence and Extent of Corneal Disturbance Associated With B+L Biotrue MPS Used With B+L PureVision Lenses: Complete Statistical AnalysisIndependent statistical analysis of Study of the Presence and Extent of Corneal Disturbance Associated With B+L Biotrue MPS Used With B+L PureVision Lenses: primary endpoint results, effect estimate with confidence interval, sample-size…